Glioblastoma Readout could mark a change for Diffusion Pharma
Diffusion Pharmaceuticals Inc. (DFFN) has a current market cap of $7.6 million, but on a fully...
Read Moreby Mike Sheikh | Nov 25, 2019 | Cancer, Companies, Drug Trial, Pharmaceutical | 0 |
Diffusion Pharmaceuticals Inc. (DFFN) has a current market cap of $7.6 million, but on a fully...
Read MoreShare with: